Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
STAT1
|
ENSG00000115415.14 | signal transducer and activator of transcription 1 |
STAT3
|
ENSG00000168610.10 | signal transducer and activator of transcription 3 |
BCL6
|
ENSG00000113916.13 | BCL6 transcription repressor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT1 | hg19_v2_chr2_-_191878162_191878313 | -0.50 | 3.2e-03 | Click! |
STAT3 | hg19_v2_chr17_-_40540586_40540600 | 0.32 | 7.4e-02 | Click! |
BCL6 | hg19_v2_chr3_-_187455680_187455732 | -0.28 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_230850043 | 8.64 |
ENST00000366667.4
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
chr3_-_93692681 | 6.77 |
ENST00000348974.4
|
PROS1
|
protein S (alpha) |
chr17_+_77021702 | 6.62 |
ENST00000392445.2
ENST00000354124.3 |
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr3_-_93692781 | 6.42 |
ENST00000394236.3
|
PROS1
|
protein S (alpha) |
chr17_+_32683456 | 5.83 |
ENST00000225844.2
|
CCL13
|
chemokine (C-C motif) ligand 13 |
chr9_-_117880477 | 5.49 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr1_-_68299130 | 5.32 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr12_+_53443963 | 5.23 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr3_-_148939598 | 5.20 |
ENST00000455472.3
|
CP
|
ceruloplasmin (ferroxidase) |
chr12_+_53443680 | 4.91 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr12_-_7244469 | 4.67 |
ENST00000538050.1
ENST00000536053.2 |
C1R
|
complement component 1, r subcomponent |
chr3_-_52864680 | 4.65 |
ENST00000406595.1
ENST00000485816.1 ENST00000434759.3 ENST00000346281.5 ENST00000266041.4 |
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr17_-_76356148 | 4.62 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
chrX_-_139866723 | 4.36 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
chr20_-_49308048 | 4.22 |
ENST00000327979.2
|
FAM65C
|
family with sequence similarity 65, member C |
chr15_+_84322827 | 4.10 |
ENST00000286744.5
ENST00000567476.1 |
ADAMTSL3
|
ADAMTS-like 3 |
chr12_-_7245018 | 4.04 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr1_+_207262578 | 4.04 |
ENST00000243611.5
ENST00000367076.3 |
C4BPB
|
complement component 4 binding protein, beta |
chr5_+_40909354 | 3.96 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr3_-_148939835 | 3.96 |
ENST00000264613.6
|
CP
|
ceruloplasmin (ferroxidase) |
chr19_+_35773242 | 3.67 |
ENST00000222304.3
|
HAMP
|
hepcidin antimicrobial peptide |
chr17_-_26697304 | 3.62 |
ENST00000536498.1
|
VTN
|
vitronectin |
chr4_-_185820602 | 3.58 |
ENST00000515864.1
ENST00000507183.1 |
RP11-701P16.4
|
long intergenic non-protein coding RNA 1093 |
chr4_-_155511887 | 3.36 |
ENST00000302053.3
ENST00000403106.3 |
FGA
|
fibrinogen alpha chain |
chr19_+_15218180 | 3.32 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr11_+_76493294 | 3.18 |
ENST00000533752.1
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr16_+_72088376 | 3.16 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
chr17_+_32582293 | 3.15 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
chr1_+_207262540 | 3.15 |
ENST00000452902.2
|
C4BPB
|
complement component 4 binding protein, beta |
chr3_-_149095652 | 3.04 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr16_-_10652993 | 2.99 |
ENST00000536829.1
|
EMP2
|
epithelial membrane protein 2 |
chr20_-_49307897 | 2.95 |
ENST00000535356.1
|
FAM65C
|
family with sequence similarity 65, member C |
chr9_+_97766409 | 2.94 |
ENST00000425634.2
|
C9orf3
|
chromosome 9 open reading frame 3 |
chr7_+_134464414 | 2.75 |
ENST00000361901.2
|
CALD1
|
caldesmon 1 |
chr14_-_25519095 | 2.67 |
ENST00000419632.2
ENST00000358326.2 ENST00000396700.1 ENST00000548724.1 |
STXBP6
|
syntaxin binding protein 6 (amisyn) |
chr19_-_58864848 | 2.64 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
chr8_+_19759228 | 2.63 |
ENST00000520959.1
|
LPL
|
lipoprotein lipase |
chr1_+_202431859 | 2.62 |
ENST00000391959.3
ENST00000367270.4 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr9_-_117853297 | 2.55 |
ENST00000542877.1
ENST00000537320.1 ENST00000341037.4 |
TNC
|
tenascin C |
chr7_+_134464376 | 2.53 |
ENST00000454108.1
ENST00000361675.2 |
CALD1
|
caldesmon 1 |
chr1_+_207262627 | 2.52 |
ENST00000391923.1
|
C4BPB
|
complement component 4 binding protein, beta |
chr1_+_207262170 | 2.51 |
ENST00000367078.3
|
C4BPB
|
complement component 4 binding protein, beta |
chr2_-_190044480 | 2.41 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr3_-_145940126 | 2.37 |
ENST00000498625.1
|
PLSCR4
|
phospholipid scramblase 4 |
chr17_+_40912764 | 2.35 |
ENST00000589683.1
ENST00000588928.1 |
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr11_+_57365150 | 2.32 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr9_+_97766469 | 2.31 |
ENST00000433691.2
|
C9orf3
|
chromosome 9 open reading frame 3 |
chr22_-_50699701 | 2.30 |
ENST00000395780.1
|
MAPK12
|
mitogen-activated protein kinase 12 |
chr4_-_155533787 | 2.28 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
chr3_-_145940214 | 2.24 |
ENST00000481701.1
|
PLSCR4
|
phospholipid scramblase 4 |
chrX_-_154563889 | 2.24 |
ENST00000369449.2
ENST00000321926.4 |
CLIC2
|
chloride intracellular channel 2 |
chr22_+_33197683 | 2.20 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr19_-_4717835 | 2.13 |
ENST00000599248.1
|
DPP9
|
dipeptidyl-peptidase 9 |
chr1_-_153521714 | 2.10 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr9_+_70971815 | 2.10 |
ENST00000396392.1
ENST00000396396.1 |
PGM5
|
phosphoglucomutase 5 |
chr11_+_57531292 | 2.09 |
ENST00000524579.1
|
CTNND1
|
catenin (cadherin-associated protein), delta 1 |
chr10_-_33625154 | 2.08 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
chr7_-_87936195 | 2.06 |
ENST00000414498.1
ENST00000301959.5 ENST00000380079.4 |
STEAP4
|
STEAP family member 4 |
chr9_+_92316557 | 2.06 |
ENST00000444374.1
|
RP11-316P17.2
|
RP11-316P17.2 |
chr1_-_147245445 | 2.05 |
ENST00000430508.1
|
GJA5
|
gap junction protein, alpha 5, 40kDa |
chr11_-_102668879 | 2.05 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr12_+_93964746 | 1.95 |
ENST00000536696.2
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr11_+_46740730 | 1.91 |
ENST00000311907.5
ENST00000530231.1 ENST00000442468.1 |
F2
|
coagulation factor II (thrombin) |
chr5_-_42812143 | 1.89 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr1_-_147245484 | 1.88 |
ENST00000271348.2
|
GJA5
|
gap junction protein, alpha 5, 40kDa |
chr5_-_146781153 | 1.87 |
ENST00000520473.1
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr1_+_22979474 | 1.87 |
ENST00000509305.1
|
C1QB
|
complement component 1, q subcomponent, B chain |
chr11_+_7506837 | 1.87 |
ENST00000528758.1
|
OLFML1
|
olfactomedin-like 1 |
chr12_-_21928515 | 1.85 |
ENST00000537950.1
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr12_-_91539918 | 1.82 |
ENST00000548218.1
|
DCN
|
decorin |
chr10_-_90751038 | 1.81 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr2_-_128399706 | 1.78 |
ENST00000426981.1
|
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
chr1_+_155099927 | 1.78 |
ENST00000368407.3
|
EFNA1
|
ephrin-A1 |
chr1_+_22979676 | 1.75 |
ENST00000432749.2
ENST00000314933.6 |
C1QB
|
complement component 1, q subcomponent, B chain |
chr14_-_94919103 | 1.74 |
ENST00000334708.3
|
SERPINA11
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
chr14_-_21270995 | 1.69 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_+_56880606 | 1.67 |
ENST00000451914.1
|
RP4-710M16.2
|
RP4-710M16.2 |
chrX_-_10544942 | 1.63 |
ENST00000380779.1
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr4_-_110723134 | 1.61 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr5_-_122372354 | 1.61 |
ENST00000306442.4
|
PPIC
|
peptidylprolyl isomerase C (cyclophilin C) |
chr8_-_86253888 | 1.59 |
ENST00000522389.1
ENST00000432364.2 ENST00000517618.1 |
CA1
|
carbonic anhydrase I |
chr6_-_46889694 | 1.59 |
ENST00000283296.7
ENST00000362015.4 ENST00000456426.2 |
GPR116
|
G protein-coupled receptor 116 |
chr4_-_110723335 | 1.58 |
ENST00000394634.2
|
CFI
|
complement factor I |
chr8_-_120651020 | 1.57 |
ENST00000522826.1
ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr1_+_214163033 | 1.56 |
ENST00000607425.1
|
PROX1
|
prospero homeobox 1 |
chr4_-_110723194 | 1.54 |
ENST00000394635.3
|
CFI
|
complement factor I |
chr22_-_31503490 | 1.53 |
ENST00000400299.2
|
SELM
|
Selenoprotein M |
chr7_+_117120017 | 1.53 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr1_-_11107280 | 1.51 |
ENST00000400897.3
ENST00000400898.3 |
MASP2
|
mannan-binding lectin serine peptidase 2 |
chr8_-_82395461 | 1.51 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
chr5_+_38845960 | 1.51 |
ENST00000502536.1
|
OSMR
|
oncostatin M receptor |
chr2_-_105030466 | 1.49 |
ENST00000449772.1
|
AC068535.3
|
AC068535.3 |
chr3_-_112329110 | 1.47 |
ENST00000479368.1
|
CCDC80
|
coiled-coil domain containing 80 |
chr9_-_89562104 | 1.47 |
ENST00000298743.7
|
GAS1
|
growth arrest-specific 1 |
chr8_+_30300119 | 1.47 |
ENST00000520191.1
|
RBPMS
|
RNA binding protein with multiple splicing |
chr1_-_144994909 | 1.47 |
ENST00000369347.4
ENST00000369354.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr19_+_10381769 | 1.47 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr5_+_140501581 | 1.46 |
ENST00000194152.1
|
PCDHB4
|
protocadherin beta 4 |
chr14_-_21270561 | 1.46 |
ENST00000412779.2
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_-_144995074 | 1.46 |
ENST00000534536.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr9_+_133231604 | 1.46 |
ENST00000442930.1
|
HMCN2
|
hemicentin 2 |
chr18_+_21464737 | 1.42 |
ENST00000586751.1
|
LAMA3
|
laminin, alpha 3 |
chr1_-_112903150 | 1.41 |
ENST00000427290.1
|
RP5-965F6.2
|
RP5-965F6.2 |
chr12_-_22063787 | 1.40 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
chr8_+_19796381 | 1.38 |
ENST00000524029.1
ENST00000522701.1 ENST00000311322.8 |
LPL
|
lipoprotein lipase |
chr12_-_88974236 | 1.38 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
chr5_-_145214893 | 1.38 |
ENST00000394450.2
|
PRELID2
|
PRELI domain containing 2 |
chr1_-_153521597 | 1.37 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr5_+_38846101 | 1.36 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr14_-_25479811 | 1.36 |
ENST00000550887.1
|
STXBP6
|
syntaxin binding protein 6 (amisyn) |
chr2_+_169659121 | 1.34 |
ENST00000397206.2
ENST00000397209.2 ENST00000421711.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
chrX_+_138612889 | 1.34 |
ENST00000218099.2
ENST00000394090.2 |
F9
|
coagulation factor IX |
chr14_-_30396948 | 1.31 |
ENST00000331968.5
|
PRKD1
|
protein kinase D1 |
chr4_+_166300084 | 1.30 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
chr2_+_97203082 | 1.27 |
ENST00000454558.2
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like) |
chr11_+_112041253 | 1.26 |
ENST00000532612.1
|
AP002884.3
|
AP002884.3 |
chr2_+_169658928 | 1.26 |
ENST00000317647.7
ENST00000445023.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
chr5_+_140625147 | 1.24 |
ENST00000231173.3
|
PCDHB15
|
protocadherin beta 15 |
chr5_-_38845812 | 1.21 |
ENST00000513480.1
ENST00000512519.1 |
CTD-2127H9.1
|
CTD-2127H9.1 |
chr4_-_76957214 | 1.21 |
ENST00000306621.3
|
CXCL11
|
chemokine (C-X-C motif) ligand 11 |
chr14_+_76452090 | 1.19 |
ENST00000314067.6
ENST00000238628.6 ENST00000556742.1 |
IFT43
|
intraflagellar transport 43 homolog (Chlamydomonas) |
chr7_-_75443118 | 1.19 |
ENST00000222902.2
|
CCL24
|
chemokine (C-C motif) ligand 24 |
chr22_+_23054174 | 1.18 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr7_+_117120106 | 1.17 |
ENST00000426809.1
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr14_+_94577074 | 1.17 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr1_-_203198790 | 1.17 |
ENST00000367229.1
ENST00000255427.3 ENST00000535569.1 |
CHIT1
|
chitinase 1 (chitotriosidase) |
chr1_+_32712815 | 1.15 |
ENST00000373582.3
|
FAM167B
|
family with sequence similarity 167, member B |
chr17_-_41132088 | 1.15 |
ENST00000591916.1
ENST00000451885.2 ENST00000454303.1 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
chr19_-_4540486 | 1.13 |
ENST00000306390.6
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1 |
chr12_-_291556 | 1.12 |
ENST00000537295.1
ENST00000537961.1 |
RP11-598F7.6
|
RP11-598F7.6 |
chr14_-_107083690 | 1.11 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr8_-_6420565 | 1.09 |
ENST00000338312.6
|
ANGPT2
|
angiopoietin 2 |
chr3_-_151176497 | 1.08 |
ENST00000282466.3
|
IGSF10
|
immunoglobulin superfamily, member 10 |
chr1_+_163039143 | 1.07 |
ENST00000531057.1
ENST00000527809.1 ENST00000367908.4 |
RGS4
|
regulator of G-protein signaling 4 |
chr19_-_7812446 | 1.07 |
ENST00000394173.4
ENST00000301357.8 |
CD209
|
CD209 molecule |
chr14_-_92414294 | 1.06 |
ENST00000554468.1
|
FBLN5
|
fibulin 5 |
chr19_-_11688951 | 1.05 |
ENST00000589792.1
|
ACP5
|
acid phosphatase 5, tartrate resistant |
chr11_+_111412271 | 1.05 |
ENST00000528102.1
|
LAYN
|
layilin |
chr6_+_97010424 | 1.05 |
ENST00000541107.1
ENST00000450218.1 ENST00000326771.2 |
FHL5
|
four and a half LIM domains 5 |
chr17_-_19265982 | 1.04 |
ENST00000268841.6
ENST00000261499.4 ENST00000575478.1 |
B9D1
|
B9 protein domain 1 |
chr10_-_35104185 | 1.04 |
ENST00000374789.3
ENST00000374788.3 ENST00000346874.4 ENST00000374794.3 ENST00000350537.4 ENST00000374790.3 ENST00000374776.1 ENST00000374773.1 ENST00000545693.1 ENST00000545260.1 ENST00000340077.5 |
PARD3
|
par-3 family cell polarity regulator |
chr8_-_6420777 | 1.03 |
ENST00000415216.1
|
ANGPT2
|
angiopoietin 2 |
chr2_-_106013400 | 1.02 |
ENST00000409807.1
|
FHL2
|
four and a half LIM domains 2 |
chr2_-_204398141 | 1.00 |
ENST00000428637.1
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
chr1_-_201368653 | 1.00 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
chr3_-_112356944 | 1.00 |
ENST00000461431.1
|
CCDC80
|
coiled-coil domain containing 80 |
chr8_-_6420930 | 0.99 |
ENST00000325203.5
|
ANGPT2
|
angiopoietin 2 |
chr1_-_144994840 | 0.98 |
ENST00000369351.3
ENST00000369349.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr11_+_130318869 | 0.97 |
ENST00000299164.2
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
chr16_+_30996502 | 0.97 |
ENST00000353250.5
ENST00000262520.6 ENST00000297679.5 ENST00000562932.1 ENST00000574447.1 |
HSD3B7
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
chr14_-_94759361 | 0.95 |
ENST00000393096.1
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr6_+_44194762 | 0.94 |
ENST00000371708.1
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr12_-_7261772 | 0.94 |
ENST00000545280.1
ENST00000543933.1 ENST00000545337.1 ENST00000544702.1 ENST00000266542.4 |
C1RL
|
complement component 1, r subcomponent-like |
chr14_-_94759408 | 0.94 |
ENST00000554723.1
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr1_+_162602244 | 0.94 |
ENST00000367922.3
ENST00000367921.3 |
DDR2
|
discoidin domain receptor tyrosine kinase 2 |
chr11_+_111782934 | 0.94 |
ENST00000304298.3
|
HSPB2
|
Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA. |
chr11_-_2162468 | 0.94 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr4_+_126237554 | 0.94 |
ENST00000394329.3
|
FAT4
|
FAT atypical cadherin 4 |
chr4_+_155484103 | 0.93 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr14_+_100240019 | 0.93 |
ENST00000556199.1
|
EML1
|
echinoderm microtubule associated protein like 1 |
chr11_-_6462210 | 0.92 |
ENST00000265983.3
|
HPX
|
hemopexin |
chr17_-_9694614 | 0.91 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
chr15_+_74466012 | 0.91 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr14_-_24977457 | 0.91 |
ENST00000250378.3
ENST00000206446.4 |
CMA1
|
chymase 1, mast cell |
chr1_+_1370903 | 0.90 |
ENST00000338660.5
ENST00000404702.3 ENST00000476993.1 ENST00000471398.1 |
VWA1
|
von Willebrand factor A domain containing 1 |
chr14_-_94759595 | 0.90 |
ENST00000261994.4
|
SERPINA10
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr4_+_155484155 | 0.90 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
chr1_-_201368707 | 0.90 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr1_-_154946825 | 0.90 |
ENST00000368453.4
ENST00000368450.1 ENST00000366442.2 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr6_-_110011718 | 0.90 |
ENST00000532976.1
|
AK9
|
adenylate kinase 9 |
chr5_-_140013275 | 0.89 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr22_+_38597889 | 0.89 |
ENST00000338483.2
ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr14_-_106406090 | 0.89 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr17_-_19265855 | 0.89 |
ENST00000440841.1
ENST00000395615.1 ENST00000461069.2 |
B9D1
|
B9 protein domain 1 |
chr3_+_45067659 | 0.89 |
ENST00000296130.4
|
CLEC3B
|
C-type lectin domain family 3, member B |
chr1_+_16083154 | 0.88 |
ENST00000375771.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr2_+_173686303 | 0.88 |
ENST00000397087.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr3_+_112930946 | 0.88 |
ENST00000462425.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr10_-_48416849 | 0.87 |
ENST00000249598.1
|
GDF2
|
growth differentiation factor 2 |
chr19_-_49339732 | 0.86 |
ENST00000599157.1
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14 |
chr22_-_36357671 | 0.86 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr19_-_49339915 | 0.86 |
ENST00000263278.4
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14 |
chr7_-_74267836 | 0.86 |
ENST00000361071.5
ENST00000453619.2 ENST00000417115.2 ENST00000405086.2 |
GTF2IRD2
|
GTF2I repeat domain containing 2 |
chr6_+_125540951 | 0.85 |
ENST00000524679.1
|
TPD52L1
|
tumor protein D52-like 1 |
chr1_-_144995002 | 0.85 |
ENST00000369356.4
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr4_+_55096010 | 0.85 |
ENST00000503856.1
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr1_+_16083098 | 0.85 |
ENST00000496928.2
ENST00000508310.1 |
FBLIM1
|
filamin binding LIM protein 1 |
chr11_-_2162162 | 0.84 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr17_-_73505961 | 0.84 |
ENST00000433559.2
|
CASKIN2
|
CASK interacting protein 2 |
chr11_-_111782484 | 0.84 |
ENST00000533971.1
|
CRYAB
|
crystallin, alpha B |
chr1_+_207262881 | 0.83 |
ENST00000451804.2
|
C4BPB
|
complement component 4 binding protein, beta |
chr1_-_31845914 | 0.83 |
ENST00000373713.2
|
FABP3
|
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
chr1_+_26485511 | 0.83 |
ENST00000374268.3
|
FAM110D
|
family with sequence similarity 110, member D |
chr14_-_76447336 | 0.83 |
ENST00000556285.1
|
TGFB3
|
transforming growth factor, beta 3 |
chr22_+_38609538 | 0.82 |
ENST00000407965.1
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
chr17_+_76356516 | 0.82 |
ENST00000592569.1
|
RP11-806H10.4
|
RP11-806H10.4 |
chrX_-_65253506 | 0.82 |
ENST00000427538.1
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chr5_+_140723601 | 0.81 |
ENST00000253812.6
|
PCDHGA3
|
protocadherin gamma subfamily A, 3 |
chr11_-_115127611 | 0.81 |
ENST00000545094.1
|
CADM1
|
cell adhesion molecule 1 |
chr3_+_136537911 | 0.81 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
1.9 | 5.8 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
1.6 | 8.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.3 | 3.9 | GO:0098906 | atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
1.3 | 13.0 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
1.2 | 3.7 | GO:1990641 | cellular response to bile acid(GO:1903413) response to iron ion starvation(GO:1990641) |
1.1 | 3.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
1.1 | 3.2 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.9 | 3.7 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.9 | 4.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 16.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.8 | 3.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.8 | 6.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 2.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 3.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 2.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.7 | 2.7 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.6 | 2.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 1.6 | GO:0006756 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.5 | 1.6 | GO:0042704 | detection of oxygen(GO:0003032) uterine wall breakdown(GO:0042704) |
0.5 | 1.6 | GO:0061114 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.5 | 0.9 | GO:0090264 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
0.5 | 1.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.4 | 4.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 2.1 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 2.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.4 | 5.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.4 | 2.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 11.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 1.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 0.9 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.3 | 0.9 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.3 | 2.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 1.8 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 4.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 3.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 2.5 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.7 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.2 | 5.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.2 | 1.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.7 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 0.7 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.2 | 0.9 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.2 | 1.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.2 | 0.8 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.2 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 1.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 1.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.2 | 1.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 3.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.2 | 0.9 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 0.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 0.6 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 4.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.5 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.2 | 1.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 0.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.2 | 2.0 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.1 | 22.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.3 | GO:1901727 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.3 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 2.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 1.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.5 | GO:0071506 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.5 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.8 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 2.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.6 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 2.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 1.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 2.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.3 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.1 | 0.4 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 2.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 1.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 1.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) vitamin E metabolic process(GO:0042360) |
0.1 | 0.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 2.7 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.3 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.1 | 1.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 1.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 1.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.5 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 5.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 2.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 2.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.3 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) |
0.1 | 0.4 | GO:1903772 | virus maturation(GO:0019075) regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 1.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.3 | GO:0097017 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) renal protein absorption(GO:0097017) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 4.2 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.5 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.4 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 2.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.3 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.0 | 0.5 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.0 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 1.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 1.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 2.6 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.2 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.0 | 0.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 3.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.3 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.0 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 1.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.6 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 1.9 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.4 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.0 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.8 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 1.3 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.0 | 1.8 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.3 | GO:0061303 | keratan sulfate catabolic process(GO:0042340) cornea development in camera-type eye(GO:0061303) |
0.0 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.0 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 3.6 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 1.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 1.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.3 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.1 | GO:0071105 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
0.0 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 1.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.7 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 1.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.9 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 2.7 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.0 | 0.5 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.0 | 0.6 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.4 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.4 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 3.3 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.0 | 0.7 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.0 | 2.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.4 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.0 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.6 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 1.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0044299 | C-fiber(GO:0044299) |
1.0 | 2.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.9 | 3.6 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.8 | 2.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 3.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 3.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.5 | 7.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 4.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 7.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 3.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 5.6 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 11.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 2.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.3 | 1.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 50.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 4.0 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 3.3 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 1.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.7 | GO:0031673 | H zone(GO:0031673) |
0.1 | 1.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 14.7 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 2.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 4.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 1.6 | GO:0032059 | bleb(GO:0032059) |
0.1 | 1.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 5.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 3.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 7.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 5.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 4.3 | GO:0031672 | A band(GO:0031672) |
0.0 | 2.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 1.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.5 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.7 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 1.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 3.9 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 1.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 1.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 1.4 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.3 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 1.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 2.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 6.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.0 | GO:0000806 | Y chromosome(GO:0000806) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.3 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 9.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.3 | 3.9 | GO:0086079 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
1.0 | 4.0 | GO:0017129 | triglyceride binding(GO:0017129) |
0.8 | 8.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 9.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.7 | 2.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.5 | 3.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 2.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 1.9 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 3.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.4 | 0.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 8.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 1.7 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.4 | 2.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 1.5 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.4 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 1.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.3 | 2.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.3 | 2.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 1.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.8 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.2 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 1.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 5.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.5 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 2.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.6 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 1.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 4.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.6 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.2 | 0.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.2 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 0.5 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.2 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 5.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 4.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 4.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 4.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 2.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.6 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 2.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 1.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.8 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.7 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.1 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 2.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 24.9 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 10.2 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 4.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 2.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 18.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 2.1 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.0 | 2.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.7 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 2.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.3 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.0 | 0.1 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.0 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 1.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.0 | 2.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 4.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.1 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 4.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 2.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 3.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 19.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 9.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 13.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 8.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 3.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 9.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 21.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.0 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 1.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 1.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 10.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 9.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 2.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.9 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 22.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 17.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 9.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 4.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 5.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 8.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 5.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 3.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 3.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 9.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 5.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 3.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 14.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 2.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 12.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 3.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 2.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.4 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 3.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 4.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 3.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.0 | 0.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |